2,067 Results
Pharma AI & Data Congress 2026 launches June 3 in Mumbai for 130+ pharma IT leaders to tackle AI deployment under GAMP AI, EU AI Act, and DPDPA compliance.
Team Pharma Now | May 09, 2026
FDA approved zenocutuzumab-zbco for NRG1-fusion cholangiocarcinoma five months ahead of goal date under the CNPV pilot program.
Pharma Now Editorial Team | May 09, 2026
Moleculin Biotech adds Hong Kong to its Annamycin IP portfolio ahead of imminent Phase 3 data, extending formulation exclusivity through 2040.
Vaibhavi M. | May 08, 2026
FDA's final guidance on postapproval pregnancy safety studies sets a methodological framework covering registries, real-world data, and case-based descriptive studies.
Pharma Now Editorial Team | May 08, 2026
FDA finalizes pulmonary TB drug development guidance under docket FDA-2013-D-1319, setting clinical trial expectations for antibacterial sponsors.
Pharma Now Editorial Team | May 08, 2026
FDA finalizes CDI drug development guidance under docket FDA-2022-D-1261, covering treatment, recurrence reduction, and prevention indication pathways.
Pharma Now Editorial Team | May 08, 2026
A full timeline of the MV Hondius hantavirus outbreak, from the first case on April 6 to three deaths, 12 nations on alert, and coordinated disembarkation scheduled for May 11.
Vaibhavi M. | May 08, 2026